UC Riverside |

Why is it taking so long to approve a COVID-19 vaccine for kids?

UC Riverside vaccine expert David Lo explains the reasons behind the wait.

UCSF |

The Kidney Project successfully tests a prototype bioartificial kidney

Taking another big step toward becoming reality, Shuvo Roy's project is awarded KidneyX’s Artificial Kidney Prize.

UC Riverside |

Grow and eat your own vaccines?

A new project will study whether edible plants like lettuce into mRNA vaccine factories.

UC San Diego |

It’s not just SARS-CoV-2: Most respiratory viruses spread by aerosols

Our conventional wisdom on viral disease transmission needs revision, an international science team finds.

UC Riverside via The Conversation |

How the Purdue opioid settlement could help the public understand the roots of the drug crisis

The multibillion-dollar settlement will trigger the release of troves of documents that may shine new light on what caused the opioid crisis.

UC Davis |

Both sucrose and high fructose corn syrup linked to increased health risks

Sucrose, a more 'natural' form of sugar, may be just as bad for your health.

UCSF |

Struggling to learn a new language? Blame it on your stable brain

A new study sheds light on the age-old question of why it’s so difficult to learn a second language as an adult.

UC Berkeley |

How much wildfire smoke is infiltrating our homes?

Scientists investigate what homes are best at keeping the smoke out and what we can do to keep our air cleaner.

UCSF |

COVID-19 during pregnancy associated with preterm birth

People of color face disproportionate infection risk while pregnant, large study finds.

UC Davis |

LGBTQ+ youth face increased anxiety amid COVID-19 pandemic

Using social media, research identifies stressors among an already vulnerable population.

UC San Diego |

Second breath: Region’s first double lung transplant for COVID-19 patient

Facing a ventilator-bound future, Federico Gomez Gil can finally breathe freely again, thanks to the help of a UC San Diego Health team.

UC Berkeley |

Using two CRISPR enzymes, a COVID diagnostic in only 20 minutes

Eliminating RNA amplification simplifies and speeds up assay for SARS-CoV-2 virus, making it ideal for point of care testing.